Researcher.Life Logo

Journal of Child and Adolescent Psychopharmacology : Impact Factor & More

eISSN: 1557-8992pISSN: 1044-5463

Key Metrics

CiteScore
4.1
H-Index
90
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Child and Adolescent Psychopharmacology

Journal of Child and Adolescent Psychopharmacology Journal Specifications

Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1990
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Child and Adolescent Psychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Child and Adolescent Psychopharmacology

Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome.
  • 13 May 2026
  • Journal of child and adolescent psychopharmacology
Manganese Exposure and Attention-Deficit/Hyperactivity Disorder-Related Neurobehavioral Outcomes in Children: A Systematic Review of Human Studies.
  • 13 May 2026
  • Journal of child and adolescent psychopharmacology
Prediction Gone Awry: A Computational Framework for Emotion Dysregulation Across Autism and Attention-Deficit/Hyperactivity Disorder.
  • 11 May 2026
  • Journal of child and adolescent psychopharmacology
Letter: Without a Broader Understanding of the Variables Involved in the Brain-Gut Axis, Probiotics Use Is still an Open Question.
  • 8 May 2026
  • Journal of child and adolescent psychopharmacology
Age-Related Patterns and Longitudinal Trends in Psychotropic Medication Use Among Commercially Insured Children with Autism Spectrum Disorder in the United States: A Claims Database Study.
  • 5 May 2026
  • Journal of child and adolescent psychopharmacology
Cardiac Biomarkers as Potential Indicators of Neuroimaging Brain Changes in Children and Young Adults with Psychiatric Disorders: A Systematic Review.
  • 5 May 2026
  • Journal of child and adolescent psychopharmacology
Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome.
  • 13 May 2026
  • Journal of child and adolescent psychopharmacology
Manganese Exposure and Attention-Deficit/Hyperactivity Disorder-Related Neurobehavioral Outcomes in Children: A Systematic Review of Human Studies.
  • 13 May 2026
  • Journal of child and adolescent psychopharmacology
Prediction Gone Awry: A Computational Framework for Emotion Dysregulation Across Autism and Attention-Deficit/Hyperactivity Disorder.
  • 11 May 2026
  • Journal of child and adolescent psychopharmacology
Letter: Without a Broader Understanding of the Variables Involved in the Brain-Gut Axis, Probiotics Use Is still an Open Question.
  • 8 May 2026
  • Journal of child and adolescent psychopharmacology
Age-Related Patterns and Longitudinal Trends in Psychotropic Medication Use Among Commercially Insured Children with Autism Spectrum Disorder in the United States: A Claims Database Study.
  • 5 May 2026
  • Journal of child and adolescent psychopharmacology
Cardiac Biomarkers as Potential Indicators of Neuroimaging Brain Changes in Children and Young Adults with Psychiatric Disorders: A Systematic Review.
  • 5 May 2026
  • Journal of child and adolescent psychopharmacology

FAQs on Journal of Child and Adolescent Psychopharmacology